Last reviewed · How we verify
NCT03905954
The Impact of a Diagnosis of Parkinson's on Work
trial testing Usual care in Parkinson Disease in 696 participants. Completed in 4 November 2019.
4 November 2019
Quick facts
| Lead sponsor | Oxford Brookes University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 696 |
| Start date | 11 April 2019 |
| Primary completion | 4 November 2019 |
| Estimated completion | 4 November 2019 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Usual care
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
Oxford Brookes University
Who can join
Adults 18 to 99, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parkinson's disease leads to loss of employment on average within less than 10 years of disease onset and has been found to be associated with an increased absence from work. This combined with hospitalisation; use of secondary health services; drug usage; and caregivers needing to give up work contributed to the costs associated with the conditions. It has been estimated that early support for working age newly diagnosed would cost the government about 1.5 million Euro in the UK but might lead to a potential cost saving of over half a billion over 5 years. The study will explore the impact of a Parkinson diagnosis on employment. The study will be survey based and will include demographic questions: age, age at diagnosis of PD, educational level, and Nationality; questions pertaining to employment type, history, and reasons for leaving if this happened; and also general health.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lost employment potential and supporting people with Parkinson's to stay in work: insights from a Pan European cross-sectional survey.
Collett J, Brusco N, Cordell N, Cockroft A, et al · · 2023 · cited 10× · PMID 35249423 · DOI 10.1080/09638288.2022.2043460
Verify or expand the search:
- PubMed search for NCT03905954
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Usual care
Trials testing the same drug.
- NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
- NCT07350473 — Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes · NA · not yet recruiting
- NCT06381661 — Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Tra · Phase 2 · not yet recruiting
- NCT07465744 — Evaluation of the Support Program to Enhance Self-management Capacity Among Stroke Survivors · NA · not yet recruiting
- NCT07278947 — ACT-based Parenting Program for Caregivers of Children With Hearing Loss Post-cochlear: A Pilot Randomised Controlled Tr · NA · not yet recruiting
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Oxford Brookes University trials
Trials by the same sponsor.
- NCT06159296 — Effect of Inhaled Hydroxy Gas on Long COVID Symptoms · NA · unknown
- NCT05888584 — Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients · NA · recruiting
- NCT05780164 — Improving Access to Lung Cancer Clinical Trials · recruiting
- NCT05839860 — Salt Intake, Hydration Status and Gastrointestinal Discomfort During Fasting · NA · completed
- NCT05412654 — Potassium Supplementation to Reduce Blood Pressure · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03905954 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oxford Brookes University
- Last refreshed: 3 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03905954.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing